Manufacturer record
Shivam Enterprises (Pharma Division): regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Shivam Enterprises (Pharma Division) (Himachal Pradesh) were declared Not of Standard Quality between October 2021 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Shivam Enterprises (Pharma Division) in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Levocetirizine HCl & Montelukast Sodium Syrup. | SL-151Mfg 2025-06 · Exp 2027-05 | Assay Of Montelukast Sodium I.P. ? Less than prescribed limit.Assay | SDFTL US Nagar,UKState lab | Jun 2026 |
| Ampholis Injection ? 10 ml (Amphotericin B Emulsion Injection) | SI-515Mfg 2021-06 · Exp 2023-05 | pH, Bacterial endotoxins and SterilitySterility | CDL KolkataCDSCO lab | Dec 2022 |
| Ranitidine HCl Injection IP 50 mg/2 ml-2ml | SI-727Mfg 2020-03 · Exp 2022-02 | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Oct 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.